Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
decrease reverse » decreased levels (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
Showing 141 - 160 results of 74,168 for search '(( significantly ((nn decrease) OR (a decrease)) ) OR ( significant decrease reverse ))', query time: 1.09s Refine Results
  1. 141
    Effects of Glu on CCTα mRNA and protein levels in cultured lungs.

    Effects of Glu on CCTα mRNA and protein levels in cultured lungs. by Xiao-Hong Li (286234)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  2. 142
    Effects of Glu on NMDAR1 expression in cultured lungs.

    Effects of Glu on NMDAR1 expression in cultured lungs. by Xiao-Hong Li (286234)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  3. 143
    Effects of Glu on PC synthesis in cultured lungs.

    Effects of Glu on PC synthesis in cultured lungs. by Xiao-Hong Li (286234)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  4. 144
    Effects of Sp1 on the mRNA and protein expression of CCTα in A549 cells.

    Effects of Sp1 on the mRNA and protein expression of CCTα in A549 cells. by Xiao-Hong Li (286234)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  5. 145
    Exercise is associated with a decrease in BMI.

    Exercise is associated with a decrease in BMI. by Stephanie Y. Yang (8384520)

    Published 2022
    “…<p>There was a significant association between a greater number of exercise sessions attended and decreased BMI over the 6-month intervention period.…”
    Save to List
    Saved in:
  6. 146
    Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B).

    Significantly decreased adhesion to host cells by the Δ<i>tad123</i> mutant (A) and time-dependent recovery (B). by Tra-My Duong-Nu (7300970)

    Published 2019
    Save to List
    Saved in:
  7. 147
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 148
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 149
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 150
    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay

    Functional Delivery Systems for Targeting Tumor Heterogeneity: Reversing Immunosuppression and Modulating Cancer-Immune Interplay by Di Han (618795)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 151
    Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED).

    Number of patients with a significant increase or significant decrease between the baseline measurement (SCr-BL) and the creatinine measurement at emergency department presentation (SCr-ED). by M. S. A. Niemantsverdriet (11886431)

    Published 2021
    Save to List
    Saved in:
  12. 152
    GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value).

    GO analysis of stage-salient genes in the order of decreasing significance (i.e, increasing p–value). by Sangeetha Muthamilselvan (8966006)

    Published 2022
    Save to List
    Saved in:
  13. 153
    Compressed sensing decoded pooled testing significantly decreases the number of tests required to identify infected samples.

    Compressed sensing decoded pooled testing significantly decreases the number of tests required to identify infected samples. by Kody A. Waldstein (14002708)

    Published 2022
    Save to List
    Saved in:
  14. 154
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 155
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 156
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 157
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 158
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 159
    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease

    Discovery of a Trifluoromethoxy Cyclopentanone Benzothiazole Receptor-Interacting Protein Kinase 1 Inhibitor as the Treatment for Alzheimer’s Disease by Yi Sun (118759)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 160
    Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors.

    Effects of 1466 on capsid and pgRNA encapsidation compared to known CAM-A and CAM-E inhibitors. by Daniel P. Bradley (10306893)

    Published 2025
    Save to List
    Saved in:

Search Tools: